Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9D2Q2

Entry ID Method Resolution Chain Position Source
AF-Q9D2Q2-F1 Predicted AlphaFoldDB

69 variants for Q9D2Q2

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388753456 29 E>K No EVA
rs3388745490 39 C>Y No EVA
rs252489227 47 G>V No EVA
rs233356287 64 Q>L No EVA
rs214949957 68 L>P No EVA
rs251492906 69 E>D No EVA
rs3388742174 83 S>* No EVA
rs3388739525 107 Q>* No EVA
rs3388756032 109 L>I No EVA
rs237231582 121 C>Y No EVA
rs3388756079 143 I>T No EVA
rs3388762110 160 V>I No EVA
rs3395074282 181 N>E No EVA
rs3388753814 186 T>A No EVA
rs3388757649 233 K>E No EVA
rs3388742147 237 W>* No EVA
rs3388762136 237 W>* No EVA
rs3388756648 238 A>V No EVA
rs3388745553 239 V>G No EVA
rs3388756665 252 L>M No EVA
rs32627357 254 S>C No EVA
rs3388757199 261 M>I No EVA
rs3388753373 281 D>V No EVA
rs3388753417 293 A>V No EVA
rs3388758631 320 C>* No EVA
rs3388757711 341 I>S No EVA
rs261953412 349 M>T No EVA
rs265505569 366 E>K No EVA
rs864279523 369 F>Y No EVA
rs3388750718 371 G>D No EVA
rs3388750673 394 S>P No EVA
rs3395410848 410 F>I No EVA
rs3395451266 410 F>L No EVA
rs3395384052 415 Q>K No EVA
rs254932046 463 T>S No EVA
rs32633300 477 T>A No EVA
rs3388753422 478 R>Q No EVA
rs3388750763 487 P>S No EVA
rs3388728082 495 H>Q No EVA
rs223818090 495 H>R No EVA
rs237470087 495 H>Y No EVA
rs3388748421 496 A>S No EVA
rs224273761 516 V>I No EVA
rs32633303 517 N>D No EVA
rs32634165 528 A>D No EVA
rs218788421 530 E>D No EVA
rs248074754 534 G>E No EVA
rs235065389 537 A>T No EVA
rs3388748371 545 F>S No EVA
rs3388748366 556 N>T No EVA
rs3388753783 569 V>I No EVA
rs237580165 579 R>S No EVA
rs225161585 580 K>R No EVA
rs214783042 585 G>A No EVA
rs250338217 591 S>N No EVA
rs32634167 592 L>M No EVA
rs255775403 594 P>T No EVA
rs1132944257 620 R>Q No EVA
rs253973811 620 R>W No EVA
rs3388742148 621 E>V No EVA
rs3388753449 633 H>Q No EVA
rs263925342 640 N>S No EVA
rs32635335 649 R>W No EVA
rs231415943 650 Q>R No EVA
rs32635337 662 Q>R No EVA
rs3388753465 671 T>A No EVA
rs3411762407 681 P>S No EVA
rs3388762118 692 P>L No EVA
rs3388753390 695 H>D No EVA

No associated diseases with Q9D2Q2

1 regional properties for Q9D2Q2

Type Name Position InterPro Accession
domain Zinc finger, CCCH-type 669 - 698 IPR000571

Functions

Description
EC Number 2.1.1.211 Methyltransferases
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

3 GO annotations of molecular function

Name Definition
metal ion binding Binding to a metal ion.
tRNA (uracil) methyltransferase activity Catalysis of the transfer of a methyl group from a donor to a uracil residue in a tRNA molecule.
tRNA (uracil-2'-O-)-methyltransferase activity Catalysis of the reaction: S-adenosyl-L-methionine + tRNA = S-adenosyl-L-homocysteine + tRNA containing 2'-O-methyluracil.

1 GO annotations of biological process

Name Definition
tRNA methylation The posttranscriptional addition of methyl groups to specific residues in a tRNA molecule.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q8IYL2 TRMT44 Probable tRNA (uracil-O(2)-)-methyltransferase Homo sapiens (Human) PR
10 20 30 40 50 60
MEELGRVRLS DPDALLPAGF WAAVTVWLER PQVANKRLCG ARMEARGRTL RSHAQAECGP
70 80 90 100 110 120
RQGQGHGLER EPGQASPKGE PESGPRASRE GTAPAADLNS LWDRVSQSLV HANPEMLAFL
130 140 150 160 170 180
CGPSLGPQPE AAQELDLILR TVIPKASPHS PLTEPKKELV VQDVSSGSVT FLPLEEDNEG
190 200 210 220 230 240
NLEVKTSNVY QLHLHHNEGE WFISVLIFCP ERWHSDGVVY PKPAWLGEEL LSKLARWAVE
250 260 270 280 290 300
NRKSEFKSTL SLVSILRYSR MYQELKEKYR DMVKVWPEVT DPEKFVYEDV AIATYLLILW
310 320 330 340 350 360
EEERAEKGVT TKQSFVDLGC GNGLLVHILS NEGHPGRGID IRRRKIWDMY GPQTQLEEGS
370 380 390 400 410 420
ITPSDETLFP GVDWLIGNHS DELTPWIPVI AARSSYTCRF FVLPCCFFDF VGRYQRQQSR
430 440 450 460 470 480
KTQYREYLDF VLEVGLSCGF HVQEDCLRIP STKRVCLIGK SRTYPPSAEV WMDEQRTRYL
490 500 510 520 530 540
HSRQGHPQSR PGGAHAPSAP QTAAHDAGLQ DSCRTVNAGS ECVLEGLAAE RGAGAPAPGL
550 560 570 580 590 600
WVPGFCPREK AERVRNCAAL PRDFVDQVVL QVANLLLDRK KFNTGNSEAR SLKPWNGGGS
610 620 630 640 650 660
LSLAEVAAEL NSETLQRLKR ECGGLQTLLK NSHQVFEVLN GRVHIRDWRQ ELQRGKPPEA
670 680 690 700 710
KQNLSAAVFK TRICWFFAHH PDGCVLPAAQ CPFAHGPEEL RLSQTLKKQR QAP